Claim
The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically relevant loci in primary human cells.
a conjunction joins clauses that may be separately evaluablea comma-separated series may list several propositionsTopics
Not filed under any topic yet.
Assessment
Supported
Main unresolved issue: 7 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:55b05b79-b595-80c8-aad8-ac8e6727bbd9
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.Every quoted passage was confirmed on the page when Galedra fetched it.
Why?
Strongest counted support: GEN reports prime assembly demonstrations of exon recoding, transgene integration, and megabase-scale rearrangements in primary human cells. weight 1.800000 evidence
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Supported.
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 29 September 2026
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 28 September 2026
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 28 September 2026
Evidence for
-
From Prime assembly enables RNA-programmable, site-specific integration of medium-to-large DNA sequences in human cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Direct evidence for the new scope claim.
-
From Targeted genomic integration and rearrangement using prime assembly Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Corrected source URL; direct evidence for the new scope claim.
-
From Boston Children’s-led team develops prime assembly for large DNA insertions Read 2026-09-28 Relevance STRONG Steps 0 Counted
-
From Boston Children’s-led team develops prime assembly for large DNA insertions Read 2026-09-28 Relevance STRONG Steps 0 Counted
-
From Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Evidence against
None.
Qualifications
-
From Targeted genomic integration and rearrangement using prime assembly Read 2026-09-29 Relevance MODERATE Steps 0 Counted
Material population-scope qualifier.
-
From Prime assembly enables RNA-programmable, site-specific integration of medium-to-large DNA sequences in human cells Read 2026-09-29 Relevance MODERATE Steps 1 Counted
Material translational-scope qualifier; locus relevance is not therapeutic efficacy.
Suppressed as dependent
None.
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 6727bbd9 | NARROWS | 0a685248 |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | f9e481e9, 828e89a5, 406a0904, 4b46a1d0 |
Summary
Supported. The main support is: Independent reporting describes megabase-scale deletions, inversions, and interchromosomal rearrangements produced with prime assembly. 5aa50679
Qualifier: The counted passage specifies primary CD3+ T cells and CD34+ HSPCs, rather than an unspecified or universal population of primary human cells. 7ec60f12
Qualifier: “Therapeutically relevant loci” identifies genomic locations, but the passage does not report therapeutic efficacy, safety, or in-vivo treatment outcomes. c4cbb713
A search for evidence in the opposing direction found something; see the counted evidence. d4721e0e
Review checks: 1 of 4. coverage:55b05b79-b595-80c8-aad8-ac8e6727bbd9
Contribution history
| seq | event | detail |
|---|---|---|
| 14139 | APPENDED | |
| 14140 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 14151 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14168 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14207 | TASK_RESULT | by 1efd24fe (accepted) |
| 14209 | TASK_RESULT | by 1efd24fe (accepted) |
| 23711 | LINK_EVIDENCE | by 1efd24fe (accepted) |